319 related articles for article (PubMed ID: 15857993)
1. Nuclear localization of the Nipah virus W protein allows for inhibition of both virus- and toll-like receptor 3-triggered signaling pathways.
Shaw ML; Cardenas WB; Zamarin D; Palese P; Basler CF
J Virol; 2005 May; 79(10):6078-88. PubMed ID: 15857993
[TBL] [Abstract][Full Text] [Related]
2. Nipah virus V and W proteins have a common STAT1-binding domain yet inhibit STAT1 activation from the cytoplasmic and nuclear compartments, respectively.
Shaw ML; García-Sastre A; Palese P; Basler CF
J Virol; 2004 Jun; 78(11):5633-41. PubMed ID: 15140960
[TBL] [Abstract][Full Text] [Related]
3. Toll-like receptor 3-mediated activation of NF-kappaB and IRF3 diverges at Toll-IL-1 receptor domain-containing adapter inducing IFN-beta.
Jiang Z; Mak TW; Sen G; Li X
Proc Natl Acad Sci U S A; 2004 Mar; 101(10):3533-8. PubMed ID: 14982987
[TBL] [Abstract][Full Text] [Related]
4. Vaccinia virus protein A46R targets multiple Toll-like-interleukin-1 receptor adaptors and contributes to virulence.
Stack J; Haga IR; Schröder M; Bartlett NW; Maloney G; Reading PC; Fitzgerald KA; Smith GL; Bowie AG
J Exp Med; 2005 Mar; 201(6):1007-18. PubMed ID: 15767367
[TBL] [Abstract][Full Text] [Related]
5. Cutting edge: a novel Toll/IL-1 receptor domain-containing adapter that preferentially activates the IFN-beta promoter in the Toll-like receptor signaling.
Yamamoto M; Sato S; Mori K; Hoshino K; Takeuchi O; Takeda K; Akira S
J Immunol; 2002 Dec; 169(12):6668-72. PubMed ID: 12471095
[TBL] [Abstract][Full Text] [Related]
6. A20 is a negative regulator of IFN regulatory factor 3 signaling.
Saitoh T; Yamamoto M; Miyagishi M; Taira K; Nakanishi M; Fujita T; Akira S; Yamamoto N; Yamaoka S
J Immunol; 2005 Feb; 174(3):1507-12. PubMed ID: 15661910
[TBL] [Abstract][Full Text] [Related]
7. Hepatitis A virus suppresses RIG-I-mediated IRF-3 activation to block induction of beta interferon.
Fensterl V; Grotheer D; Berk I; Schlemminger S; Vallbracht A; Dotzauer A
J Virol; 2005 Sep; 79(17):10968-77. PubMed ID: 16103148
[TBL] [Abstract][Full Text] [Related]
8. Interactions of the Nipah Virus P, V, and W Proteins across the STAT Family of Transcription Factors.
Keiffer TR; Ciancanelli MJ; Edwards MR; Basler CF
mSphere; 2020 Dec; 5(6):. PubMed ID: 33328346
[TBL] [Abstract][Full Text] [Related]
9. Toll/IL-1 receptor domain-containing adaptor inducing IFN-beta (TRIF) associates with TNF receptor-associated factor 6 and TANK-binding kinase 1, and activates two distinct transcription factors, NF-kappa B and IFN-regulatory factor-3, in the Toll-like receptor signaling.
Sato S; Sugiyama M; Yamamoto M; Watanabe Y; Kawai T; Takeda K; Akira S
J Immunol; 2003 Oct; 171(8):4304-10. PubMed ID: 14530355
[TBL] [Abstract][Full Text] [Related]
10. Activation of TBK1 and IKKvarepsilon kinases by vesicular stomatitis virus infection and the role of viral ribonucleoprotein in the development of interferon antiviral immunity.
tenOever BR; Sharma S; Zou W; Sun Q; Grandvaux N; Julkunen I; Hemmi H; Yamamoto M; Akira S; Yeh WC; Lin R; Hiscott J
J Virol; 2004 Oct; 78(19):10636-49. PubMed ID: 15367631
[TBL] [Abstract][Full Text] [Related]
11. Poxvirus protein N1L targets the I-kappaB kinase complex, inhibits signaling to NF-kappaB by the tumor necrosis factor superfamily of receptors, and inhibits NF-kappaB and IRF3 signaling by toll-like receptors.
DiPerna G; Stack J; Bowie AG; Boyd A; Kotwal G; Zhang Z; Arvikar S; Latz E; Fitzgerald KA; Marshall WL
J Biol Chem; 2004 Aug; 279(35):36570-8. PubMed ID: 15215253
[TBL] [Abstract][Full Text] [Related]
12. IKKepsilon and TBK1 are essential components of the IRF3 signaling pathway.
Fitzgerald KA; McWhirter SM; Faia KL; Rowe DC; Latz E; Golenbock DT; Coyle AJ; Liao SM; Maniatis T
Nat Immunol; 2003 May; 4(5):491-6. PubMed ID: 12692549
[TBL] [Abstract][Full Text] [Related]
13. Inhibition of RIG-I-dependent signaling to the interferon pathway during hepatitis C virus expression and restoration of signaling by IKKepsilon.
Breiman A; Grandvaux N; Lin R; Ottone C; Akira S; Yoneyama M; Fujita T; Hiscott J; Meurs EF
J Virol; 2005 Apr; 79(7):3969-78. PubMed ID: 15767399
[TBL] [Abstract][Full Text] [Related]
14. Identification of the minimal phosphoacceptor site required for in vivo activation of interferon regulatory factor 3 in response to virus and double-stranded RNA.
Servant MJ; Grandvaux N; tenOever BR; Duguay D; Lin R; Hiscott J
J Biol Chem; 2003 Mar; 278(11):9441-7. PubMed ID: 12524442
[TBL] [Abstract][Full Text] [Related]
15. Inhibition of phosphoinositide 3-kinase enhances TRIF-dependent NF-kappa B activation and IFN-beta synthesis downstream of Toll-like receptor 3 and 4.
Aksoy E; Vanden Berghe W; Detienne S; Amraoui Z; Fitzgerald KA; Haegeman G; Goldman M; Willems F
Eur J Immunol; 2005 Jul; 35(7):2200-9. PubMed ID: 15940673
[TBL] [Abstract][Full Text] [Related]
16. Nipah virus sequesters inactive STAT1 in the nucleus via a P gene-encoded mechanism.
Ciancanelli MJ; Volchkova VA; Shaw ML; Volchkov VE; Basler CF
J Virol; 2009 Aug; 83(16):7828-41. PubMed ID: 19515782
[TBL] [Abstract][Full Text] [Related]
17. Select paramyxoviral V proteins inhibit IRF3 activation by acting as alternative substrates for inhibitor of kappaB kinase epsilon (IKKe)/TBK1.
Lu LL; Puri M; Horvath CM; Sen GC
J Biol Chem; 2008 May; 283(21):14269-76. PubMed ID: 18362155
[TBL] [Abstract][Full Text] [Related]
18. Herpes Simplex Virus 1 Serine Protease VP24 Blocks the DNA-Sensing Signal Pathway by Abrogating Activation of Interferon Regulatory Factor 3.
Zhang D; Su C; Zheng C
J Virol; 2016 Jun; 90(12):5824-5829. PubMed ID: 27076640
[TBL] [Abstract][Full Text] [Related]
19. Cutting Edge: NF-kappaB-activating kinase-associated protein 1 participates in TLR3/Toll-IL-1 homology domain-containing adapter molecule-1-mediated IFN regulatory factor 3 activation.
Sasai M; Oshiumi H; Matsumoto M; Inoue N; Fujita F; Nakanishi M; Seya T
J Immunol; 2005 Jan; 174(1):27-30. PubMed ID: 15611223
[TBL] [Abstract][Full Text] [Related]
20. The interferon regulatory factor, IRF5, is a central mediator of toll-like receptor 7 signaling.
Schoenemeyer A; Barnes BJ; Mancl ME; Latz E; Goutagny N; Pitha PM; Fitzgerald KA; Golenbock DT
J Biol Chem; 2005 Apr; 280(17):17005-12. PubMed ID: 15695821
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
